Why Eli Lilly (LLY) Dipped More Than Broader Market Today [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
The stock's change was less than the S&P 500's daily loss of 1.07%. At the same time, the Dow lost 0.97%, and the tech-heavy Nasdaq lost 1.19%. Heading into today, shares of the drugmaker had lost 1.53% over the past month, outpacing the Medical sector's loss of 5.64% and lagging the S&P 500's loss of 0.36% in that time. Market participants will be closely following the financial results of Eli Lilly in its upcoming release. In that report, analysts expect Eli Lilly to post earnings of $5.49 per share. This would mark year-over-year growth of 120.48%. Simultaneously, our latest consensus estimate expects the revenue to be $14.08 billion, showing a 50.57% escalation compared to the year-ago quarter. In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $13.17 per share and a revenue of $45.59 billion, indicating changes of +108.39% and +33.62%, respectively, from the former year. It is also important to note the recent changes to analyst estimate
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Zepbound will dominate obesity market following SURMOUNT-5 results, says analyst [Yahoo! Finance]Yahoo! Finance
- Weight loss drugs are changing the game, Eli Lilly exec says — but many still can't get them [Yahoo! Finance]Yahoo! Finance
- Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver [Forbes]Forbes
- Lilly's Obesity Drug Zepbound To Be Key Health Cost Driver For 2025 [Forbes]Forbes
- Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
LLY
Earnings
- 10/30/24 - Miss
LLY
Sec Filings
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- LLY's page on the SEC website